Real Life Pharmacology - Pharmacology Education for Health Care Professionals

Fenofibrate Pharmacology Podcast Episode 310

01.18.2024 - By Eric Christianson, PharmD; Pharmacology Expert and Clinical PharmacistPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

On this podcast episode, I discuss fenofibrate pharmacology, adverse effects, kinetics, drug interactions, and much more!

Fenofibrate is typically only used for hypertriglyceridemia. The primary risk of hypertriglyceridemia is pancreatitis so we treat these levels because of this risk.

LFTs elevation has been associated with fenofibrate use as well as myopathy. In the presence of myopathy, checking CPK may be considered.

Fenofibrate is a weak CYP2C9 inhibitor. Warfarin and phenytoin are two important medications that may be affected by the use of fenofibrate.

More episodes from Real Life Pharmacology - Pharmacology Education for Health Care Professionals